Interferon-Driven Immune Dysregulation in Down Syndrome: A Review of the Evidence
Howard Chung,1,2 Peter HR Green,1,3 Timothy C Wang,1 Xiao-Fei Kong1,3 1Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA; 2Department of Internal Medicine, Icahn School of Medicine at Mount Sinai/Queens (Queens Hospi...
Guardado en:
Autores principales: | Chung H, Green PH, Wang TC, Kong XF |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8e4b711846f244ca8c2982cd423519d0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Expression analysis of protein inhibitor of activated STAT (PIAS) genes in IFNβ-treated multiple sclerosis patients
por: Taheri M, et al.
Publicado: (2018) -
Iridin Prevented Against Lipopolysaccharide-Induced Inflammatory Responses of Macrophages via Inactivation of PKM2-Mediated Glycolytic Pathways
por: Ying ZH, et al.
Publicado: (2021) -
Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
por: Fei Qi, et al.
Publicado: (2021) -
Interferon-λ3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis
por: Read SA, et al.
Publicado: (2021) -
Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the JAK/STAT pathway
por: Zhao,Xiaoying, et al.
Publicado: (2020)